Sigyn Therapeutics, Inc.

8-K Entered a material agreement; Unregistered sale of equity Feb 20, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Sep 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Aug 15, 2025 10-Q Quarter ended 2025-03-31 May 20, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Director or officer change; Regulation FD disclosure Mar 7, 2025 8-K Director or officer change Jan 16, 2025 8-K Amended charter or bylaws Jan 6, 2025 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Unregistered sale of equity Oct 16, 2024 8-K/A Unregistered sale of equity Oct 16, 2024 8-K Unregistered sale of equity Oct 7, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 8-K Other events Jun 6, 2024 8-K Other events May 15, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Entered a material agreement Apr 16, 2024 10-K Fiscal year ended 2023-12-31 Feb 20, 2024 8-K Other events Jan 31, 2024 8-K Modified rights of security holders; Amended charter or bylaws Jan 30, 2024 8-K Entered a material agreement; Other events Jan 11, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Director or officer change Dec 12, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Other events Oct 26, 2023 8-K Regulation FD disclosure Oct 4, 2023 8-K Entered a material agreement Sep 19, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws Jul 7, 2023 8-K Other events Jun 8, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 8-K Regulation FD disclosure Apr 13, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Director or officer change Oct 5, 2022 10-Q Quarter ended 2022-06-30 Aug 15, 2022 10-Q Quarter ended 2022-03-31 May 13, 2022 10-K Fiscal year ended 2021-12-31 Mar 21, 2022 8-K Entered a material agreement; Director or officer change Mar 9, 2022